Chinese Standards Shop Partner of Google-Books Database: 169759 (Nov 10, 2019)
 HOME   Quotation   Tax   Examples Standard-List   Contact-Us   View-Cart
  

YY/T 0653-2008

Chinese Standard: 'YY/T 0653-2008'
Standard IDContents [version]USDSTEP2[PDF] delivered inStandard Title (Description)StatusRelated Standard
YY/T 0653-2008English180 Add to Cart 0--15 minutes. Auto immediate delivery. Hematology analyzer Obsolete YY/T 0653-2008
YY/T 0653-2008Chinese14 Add to Cart <=1-day [PDF from Chinese Authority, or Standard Committee, or Publishing House]

 YY/T 0653-2008 -- Click to view a PDF In 0~10 minutes time, full copy of this English-PDF will be auto-immediately delivered to your email by our cloud-server.  
Detail Information of YY/T 0653-2008; YY/T0653-2008
Description (Translated English): Hematology analyzer
Sector / Industry: Medical Device & Pharmaceutical Industry Standard (Recommended)
Classification of Chinese Standard: C44
Classification of International Standard: 11.100
Word Count Estimation: 12,121
Date of Issue: 2008-04-25
Date of Implementation: 2009-06-01
Quoted Standard: GB/T 191-2008; GB 4793.1; GB/T 14710; YY 0466-2003
Drafting Organization: Sysmex Medical Electronics (Shanghai) Co., Ltd.
Administrative Organization: National Standardization Technical Committee of Medical clinical testing laboratories and in vitro diagnostic systems
Regulation (derived from): SFDA [2008] No. 192
Proposing organization: State Food and Drug Administration
Issuing agency(ies): China Food and Drug Administration
Summary: This standard specifies the hematology analyzer terms and definitions, classification, requirements, test methods, labeling and instructions for use, packaging, transportation and storage. This standard applies to visible components of human blood for qualitative and quantitative analysis, and provide relevant information hematology analyzer (hereinafter referred to as the analyzer). This standard does not apply to the reticulocyte analyzer.

YY/T 0653-2008
YY
PHARMACEUTICAL INDUSTRY STANDARD
OF THE PEOPLE’S REPUBLIC OF CHINA
ICS 11.100
C 44
Hematology analyzer
血液分析仪
ISSUED ON. APRIL 25, 2008
IMPLEMENTED ON. JUNE 1, 2009
Issued by. China Food and Drug Administration
Table of Contents
Foreword ... 3
1 Scope ... 4
2 Normative references ... 4
3 Terms and definitions ... 4
4 Product classification ... 6
5 Technical requirements ... 6
6 Test methods ... 9
7 Labels and instructions ... 11
8 Packaging, transportation and storage ... 13
Annex A (normative) Five-classifying test method ) ... 14
Bibliography ... 17
Foreword
Annex A of this Standard is normative.
This Standard is proposed by China Food and Drug Administration.
This Standard is under the jurisdiction of National Technical Committee on Medical
Clinical Laboratory and In Vitro Diagnostic System of Standardization Administration
of China.
Drafting organizations of this Standard. Sysmex Medical Electronics (Shanghai) Co.,
Ltd., Beijing Medical Device Testing Institute, American Beckman Coulter Co., Ltd.,
Shenzhen Mindray Biomedical Electronics Co., Ltd., Jiangxi Tekang Technology Co.,
Ltd., Guilin High-tech Zone Po Litai Medical Electronics Co., Ltd., Abbott Company.
Main drafters of this Standard. Cong Yulong, Zhang Hong, Ling Li, He Yanfeng, Yan
Xiao, Xu Yong, Tang Xuehui, Zhang Sihua.
Hematology analyzer
1 Scope
This Standard specifies the terms and definitions, classification, requirements, test
methods, labels and instructions, packaging, transportation and storage of hematology
analyzers.
This Standard applies to hematology analyzers (hereinafter referred to as analyzers),
which qualitatively and quantitatively analyze the tangible components in human blood
and provide relevant information.
This standard does not apply to reticulocyte analyzers.
2 Normative references
The following standards contain provisions which, through reference in this Standard,
constitute provisions of this Standard. For dated reference, subsequent amendments
to (excluding corrections to), or revisions of, any of these publications do not apply.
However, the parties to agreements based on this Standard are encouraged to
investigate the possibility of applying the most recent editions of the standards. For
undated references, the latest edition of the normative document referred to applies.
GB/T 191-2008 Packaging - Pictorial marking for handling of goods
GB 4793.1 Safety requirements for electrical equipment for measurement, control,
and laboratory use - Part 1. General requirements (GB 4793.1-2007, IEC 61010-
1.2001, IDT)
GB/T 14710 The environmental requirements and test methods for medical
electrical equipment
YY 0466-2003 Medical devices - Symbols to be used with medical device labels
labelling and information to be supplied (ISO 15223.2000, IDT)
3 Terms and definitions
The following terms and definitions apply to this Standard.
3.1
[JJF 1001-1998, definition 5.6]
3.6
linearity
The proportional correlation between the states of two sets of measured values or
between the measured values obtained by two methods.
[NCCLS EP10-A2]
3.7
carry-over
The amount of analyte discontinuity of one measurement system carrying one
measurement sample reaction to another measurement reaction sample, thereby
erroneously affecting the expression quantity of the other detection sample.
[NCCLS EP10-A2]
4 Product classification
4.1 The hematology analyzer without white blood cell grouping function.
4.2 Two-grouping hematology analyzer. semi-automatic hematology analyzer capable
of dividing the white blood cells into large and small groups.
4.3 Three-grouping hematology analyzer. automatic hematology analyzer capable of
dividing the white blood cells into large, medium and small groups.
4.4 Five-classifying hematology analyzer. automatic hematology analyzer capable of
classifying the white blood cells into five categories (neutrophils, lymphocytes,
monocytes, eosinophils, basophils).
5 Technical requirements
5.1 Normal working conditions
5.1.1 Power supply voltage. 220 V ± 22 V; 50 Hz ± 1 Hz.
5.1.2 Ambient temperature. 18 °C ~ 25 °C.
5.1.3 Relative humidity. ≤ 80 %.
5.1.4 Atmospheric pressure. the atmospheric pressure condition claimed by the
6.3.2 Use high value samples
TAKE anticoagulation whole blood, CENTRIFUGE to remove the plasma, making it
into concentrated blood cells; gradiently dilute the concentrated blood cells with their
own platelet plasma/dilution, dilute to at least 5 concentrations, so that the high
concentration value is close to the upper limit of the linear range and the low
concentration value is close to the lower limit of the linear range. MEASURE the blood
samples of each concentration gradient on the instrument, each sample is measured
3 times, TAKE the mean value. TAKE the dilution concentration as the independent
variable, the measured mean value of each dilution concentration as the dependent
variable, to calculate the regression equation. CALCULATE the corresponding
theoretical value of each dilution concentration point by the regression equation;
CALCULATE the absolute or relative percent error between the measured mean value
and the theoretical value.
6.4 Instrument comparability
USE a well-condition hematology analyzer to measure a fresh blood sample or a
calibrator with traceability; MEASURE 5 times consecutively and calculate the mean
value of each parameter. The mean values are used as the target values; CALIBRATE
the hematology analyzer with the above-mentioned sample or calibrator. At the end of
the calibration, use another fresh blood sample to be measured five times by two
difference hematology analyzers; CALCULATE the percent deviation between the
mean values of each parameter of the two hematology analyzers.
6.5 Test of accuracy of white blood cell classification for five-classifying
analyzers
See Annex A (normative) for the test method.
6.6 Repeatability
TAKE 1 sample within the range specified in Table 2; REPEAT the measurement 10
times according to the conventional method; CALCULATE the coefficient of variation
(CV, %) according to Formula (1).
ܥܸ ൌ ݏ/̅ݔൈ100 % ... (1)
where.
s - the standard deviation of the measured values of the sample;
̅ݔ - the average of the measured values of the sample.
6.7 Carry-over
TAKE the high-value blood samples within the range of Table 4; MEASURE three times
and shall provide at least the following information.
a) product name and model;
b) production company’s name, registered address, production address and contact;
c) number or serial number directly indicated on the label affixed to the instrument;
d) power connection conditions, input power.
NOTE. The above information shall be indicated by symbols, if applicable. Any symbols used
shall comply with applicable regulations and national standards. If the symbols used do not
have existing standards, they shall be described in the relevant documents.
7.3 Instructions
The instruction shall be clear and concise, and the words shall be easy for the user to
understand. The instruction shall include at least the following contents.
a) product name and model;
b) production company’s name, registered address, production address, contact
and after-sale service organizations;
c) number of “medical device manufacturing enterprise license”, number of medical
device registration certificate;
d) product standard number;
e) product performance, main structure, scope of application, principle of detection
methods;
f) measurement procedure to be followed when using the analyzer;
g) precautions and other content requiring warnings;
h) interpretation of the graphics, symbols, abbreviations, etc. used by the analyzer
labels;
i) installation and use instructions or diagrams (including. product installation
instructions and technical drawings, circuit diagrams; the necessary
environmental conditions needed for the correct installation of the product and
the technical information t......
Related standard:   YY/T 0653-2017  YY/T 0654-2017
   
 
Privacy   ···   Product Quality   ···   About Us   ···   Refund Policy   ···   Fair Trading   ···   Quick Response
Field Test Asia Limited | Taxed in Singapore: 201302277C | Copyright 2012-2019